Amylase- and endopeptidase- and pancreatic lipase-containing product in oral dose form
RxNorm 2189991
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2189991 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Amylase- and endopeptidase- and pancreatic lipase-containing product in oral dose form.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Amylase- and endopeptidase- and pancreatic lipase-containing product in oral dose form
(Atom ID: 11435295)
FN